4th Quarter - Report

TIBER CREEK HEALTH STRATEGIES, INC. for AMGEN, INC.

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

HRSA program regarding rebates on drugs used in the outpatient setting to help low-income/uninsured populations (340B). Issues related to biosimilars.

LobbyistCovered position, as disclosed
JAMES BRYANT HALL —

Contacted: SENATE

Medicare/Medicaid MMM

Issues related to Medicare Part D. Orphan drugs.

LobbyistCovered position, as disclosed
JAMES BRYANT HALL —

Contacted: SENATE

Pharmacy PHA

ACA Implementation.

LobbyistCovered position, as disclosed
JAMES BRYANT HALL —

Contacted: SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.